{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:42:35Z","timestamp":1784634155751,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Endovascular treatment of severe intracranial atherosclerotic stenosis (ICAS) using coronary drug-eluting stents (DESs) significantly reduces the risk of in-stent restenosis (ISR) and stroke recurrence. However, there are few reports regarding the treatment of ICAS with intracranial dedicated DES. Herein, we present our experience with the feasibility, safety, and medium-term follow-up outcomes of a novel intracranial DES, named NOVA stent, in patients with symptomatic severe ICAS (\u226570%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From December 2021 to May 2022, patients with symptomatic severe ICAS who underwent implantation of the NOVA stent in our institution were retrospectively analyzed for procedural results, perioperative complications, imaging and clinical follow-up outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-four patients, 16 (66.7%) with anterior circulation lesions and 8 (33.3%) with posterior circulation lesions, were enrolled. All patients with intracranial ICA (<jats:italic>n<\/jats:italic>\u2009=\u20096), middle cerebral artery (<jats:italic>n<\/jats:italic>\u2009=\u200910), basilar artery (<jats:italic>n<\/jats:italic>\u2009=\u20093), intracranial vertebral artery (<jats:italic>n<\/jats:italic>\u2009=\u20093), and the vertebrobasilar junction (<jats:italic>n<\/jats:italic>\u2009=\u20092) stenosis were treated successfully using NOVA stents. The severity of stenosis ranged from 75 to 96% (mean 85.9%) before treatment and this was reduced to 0 to 20% (mean 8.6%) immediately after stent placement. Symptomatic distal embolism occurred in one case; however, there were no other perioperative complications. The mean follow-up duration was 12.2\u2009\u00b1\u20091.06\u2009months. No symptomatic ischemic events occurred during follow-up. Follow-up cerebral angiography was performed in 22 of 24 patients (91.7%), and significant ISR occurred in one patient (4.2%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results demonstrate that implantation of the novel intracranial DES NOVA in severe ICAS is feasible, safe, and effective in selected cases, reducing the incidence of ISR, and showing excellent midterm clinical outcomes, providing a promising option for ICAS treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1304524","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T10:27:35Z","timestamp":1711103255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Endovascular treatment of symptomatic severe intracranial atherosclerotic stenosis with a novel intracranial dedicated drug-eluting stent: a more effective treatment approach"],"prefix":"10.3389","volume":"15","author":[{"given":"Lin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Chong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Sheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/01.CIR.0000157736.19739.D0","article-title":"Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the northern Manhattan study","volume":"111","author":"White","year":"2005","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/STROKEAHA.113.003508","article-title":"Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study","volume":"45","author":"Wang","year":"2014","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp-2020-325630","article-title":"Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review","volume":"92","author":"Leng","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11910-008-0028-8","article-title":"Intracranial large artery occlusive disease","volume":"8","author":"Caplan","year":"2008","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1161\/STROKEAHA.106.477711","article-title":"A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the wingspan study","volume":"38","author":"Bose","year":"2007","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1212\/01.wnl.0000306308.08229.a3","article-title":"The NIH registry on use of the wingspan stent for symptomatic 70-99% intracranial arterial stenosis","volume":"70","author":"Zaidat","year":"2008","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.STR.0000257963.65728.e8","article-title":"US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results","volume":"38","author":"Fiorella","year":"2007","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/STROKEAHA.109.568063","article-title":"In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry","volume":"41","author":"Kurre","year":"2010","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1161\/STROKEAHA.116.016254","article-title":"Challenges in the medical Management of Symptomatic Intracranial Stenosis in an urban setting","volume":"48","author":"Sangha","year":"2017","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/01.STR.0000128708.86762.d6","article-title":"Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results","volume":"35","author":"Investigators","year":"2004","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","article-title":"Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial","volume":"383","author":"Derdeyn","year":"2014","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2015.1693","article-title":"Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial","volume":"313","author":"Zaidat","year":"2015","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1161\/STROKEAHA.113.001824","article-title":"Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis","volume":"44","author":"Jin","year":"2013","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/STROKEAHA.116.014537","article-title":"Nonprocedural symptomatic infarction and in-stent restenosis after intracranial angioplasty and stenting in the SAMMPRIS trial (stenting and aggressive medical Management for the Prevention of recurrent stroke in intracranial stenosis)","volume":"48","author":"Derdeyn","year":"2017","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/STROKEAHA.118.023996","article-title":"WEAVE trial: final results in 152 on-label patients","volume":"50","author":"Alexander","year":"2019","journal-title":"Stroke"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/neurintsurg-2020-016208","article-title":"The WOVEN trial: wingspan one-year vascular events and neurologic outcomes","volume":"13","author":"Alexander","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1161\/STROKEAHA.115.010549","article-title":"Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China","volume":"46","author":"Miao","year":"2015","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/svn-2017-000137","article-title":"Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study","volume":"3","author":"Ma","year":"2018","journal-title":"Stroke Vasc Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/01.CIR.0000112572.57794.22","article-title":"Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis","volume":"109","author":"Holmes","year":"2004","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa","year":"2005","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1253\/circj.cj-09-0059","article-title":"Molecular basis of restenosis and novel issues of drug-eluting stents","volume":"73","author":"Inoue","year":"2009","journal-title":"Circ J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1161\/01.STR.0000190893.74268.fd","article-title":"Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up","volume":"36","author":"Abou-Chebl","year":"2005","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1179\/016164105X35459","article-title":"Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease","volume":"27","author":"Boulos","year":"2005","journal-title":"Neurol Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/159101991101700217","article-title":"Drug eluting stents for symptomatic intracranial and vertebral artery stenosis","volume":"17","author":"Fields","year":"2011","journal-title":"Interv Neuroradiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5469\/neuroint.2013.8.1.9","article-title":"Long-term outcomes of drug-eluting stents in symptomatic intracranial stenosis","volume":"8","author":"Park","year":"2013","journal-title":"Neurointervention"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamaneurol.2021.4804","article-title":"Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis: a randomized clinical trial","volume":"79","author":"Jia","year":"2022","journal-title":"JAMA Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"Chimowitz","year":"2005","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1212\/wnl.45.8.1488","article-title":"The warfarin-aspirin symptomatic intracranial disease study","volume":"45","author":"Chimowitz","year":"1995","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"854226","DOI":"10.3389\/fneur.2022.854226","article-title":"Effect of a drug-eluting stent vs. bare metal stent for the treatment of symptomatic intracranial and vertebral artery stenosis","volume":"13","author":"Si","year":"2022","journal-title":"Front Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1583\/11-3718.1","article-title":"Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis","volume":"19","author":"Song","year":"2012","journal-title":"J Endovasc Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7461\/jcen.2013.15.2.85","article-title":"Comparison of drug-eluting coronary stents, bare coronary stents and self-expanding stents in angioplasty of middle cerebral artery Stenoses","volume":"15","author":"Lee","year":"2013","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jocn.2018.10.118","article-title":"Efficacy and safety of drug-eluting stent for the intracranial atherosclerotic disease: a systematic review and meta-analysis","volume":"59","author":"Ye","year":"2019","journal-title":"J Clin Neurosci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jacc.2004.11.065","article-title":"Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies","volume":"45","author":"Moreno","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1304524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T10:27:38Z","timestamp":1711103258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1304524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":36,"alternative-id":["10.3389\/fneur.2024.1304524"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1304524","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"article-number":"1304524"}}